Table 3.

Patient-reported outcomes (PROs)

	PROs assessed	PROs reported	PRO measures
PRO Domains
Emotional function	26	11	EORTC QLQ-C30a EORTC QLQ-MY20b FACT-Gc MyPOSd
Global health satus/QoL	19	16	EORTC QLQ-C30 FACT-G EuroQol 5De
Physical function	16	14	EORTC QLQ-C30 FACT-G
Social function	16	10	EORTC QLQ-C30 FACT-G
Financial burden	16	6	EORTC QLQ-C30 Financial burden
Role function	15	8	EORTC QLQ-C30
Cognitive function	15	8	EORTC QLQ-C30
Symptom index	12	8	EORTC QLQ-MY20 FACT-G MyPOS MDASI-MMf
Healthcare factors	2	2	Financial burden MyPOS
Individual symptoms
Pain	20	15	BPI-SFg EORTC QLQ-C30 NRS painh VAS paini
Fatigue	18	11	EORTC QLQ-C30 FACIT fatiguej
Dyspnea	15	8	EORTC QLQ-C30
Constipation	15	7	EORTC QLQ-C30
Nausea/vomiting	15	7	EORTC QLQ-C30
Diarrhea	15	6	EORTC QLQ-C30
Appetite loss	15	6	EORTC QLQ-C30
Sleep disturbance	15	6	EORTC QLQ-C30
Peripheral neuropathy	8	8	EORTC QLQ-CIPN20k FACT/GOG-NTXl

^aEORTC QLQ-C30 European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30.

^bEORTC QLQ-MY20 European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Myeloma 20.

^cFACT-G Functional Assessment of Cancer Therapy General.

^dMyPOS Myeloma Palliative care Outcome Scale.

^eEuroQOL 5d European Quality of Life Five Dimension.

^fMDASI-MM MD Anderson Symptom Index Multiple Myeloma.

^gBPI-SF Brief pain inventory short form.

^hNRS Pain Numeric Rating Scale Pain.

ⁱVAS Pain Visual Analog Scale Pain.

^jFACIT Fatigue Functional Assessment of Chronic Illness Therapy Fatigue.

^kEORTC QLQ-CIPN20 European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Chemotherapy Induced Peripheral Neuropathy 20.

^lFACT/GOG-NTX Functional Assessment of Cancer Therapy Gynecologic Oncology Group Neurotoxicity